Centene Corporation

68.98+0.7400+1.08%Vol 2.02M1Y Perf -15.62%
Oct 4th, 2023 16:01 DELAYED
BID67.80 ASK69.50
Open68.07 Previous Close68.98
Pre-Market- After-Market68.98
 - -  - -%
Target Price
100.00 
Analyst Rating
Moderate Buy 2.06
Potential %
44.97 
Finscreener Ranking
★★+     46.59
Insiders Trans % 3/6/12 mo.
-100/-25/-80 
Value Ranking
★+     44.29
Insiders Value % 3/6/12 mo.
-100/-17/-82 
Growth Ranking
★★★     52.40
Insiders Shares Cnt. % 3/6/12 mo.
-100/-16/-83 
Income Ranking
 —    -
Price Range Ratio 52W %
30.17 
Earnings Rating
Strong Buy
Market Cap37.35B 
Earnings Date
24th Oct 2023
Alpha-0.00 Standard Deviation0.09
Beta0.52 

Today's Price Range

67.7769.12

52W Range

60.8387.84

5 Year PE Ratio Range

14.0032.40

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
-2.15%
1 Month
11.38%
3 Months
1.29%
6 Months
6.66%
1 Year
-15.62%
3 Years
13.77%
5 Years
-4.53%
10 Years
316.41%

TickerPriceChg.Chg.%
CNC68.980.74001.08
AAPL173.661.26000.73
GOOG136.272.97002.23
MSFT318.965.56501.78
XOM111.50-4.3300-3.74
WFC38.970.30000.78
JNJ155.520.18000.12
FB196.640.99000.51
GE108.851.09001.01
JPM143.350.64000.45
Financial StrengthValueIndustryS&P 500US Markets
1.00
1.10
0.45
0.85
5.00
Leverage Ratio 3.10
ProfitabilityValueIndustryS&P 500US Markets
5.50
2.30
3.40
2.30
1.30
RevenueValueIndustryS&P 500US Markets
108.99B
192.47
24.36
24.58
Earnings HistoryEstimateReportedSurprise %
Q02 20232.052.102.44
Q01 20232.232.11-5.38
Q04 20220.870.86-1.15
Q03 20221.221.306.56
Q02 20221.731.772.31
Q01 20221.681.838.93
Q04 20210.981.013.06
Q03 20211.291.26-2.33
Earnings Per EndEstimateRevision %Trend
9/2023 QR1.474.26Positive
12/2023 QR0.81-4.71Negative
12/2023 FY6.460.31Positive
12/2024 FY6.630.15Positive
Next Report Date24th Oct 2023
Estimated EPS Next Report1.47
Estimates Count8
EPS Growth Next 5 Years %11.20
Volume Overview
Volume2.02M
Shares Outstanding541.48K
Shares Float536.77M
Trades Count31.23K
Dollar Volume138.62M
Avg. Volume3.28M
Avg. Weekly Volume2.86M
Avg. Monthly Volume3.65M
Avg. Quarterly Volume3.33M

Centene Corporation (NYSE: CNC) stock closed at 68.24 per share at the end of the most recent trading day (a -1.53% change compared to the prior day closing price) with a volume of 2.72M shares and market capitalization of 37.35B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 71300 people. Centene Corporation CEO is Michael F. Neidorff.

The one-year performance of Centene Corporation stock is -15.62%, while year-to-date (YTD) performance is -16.79%. CNC stock has a five-year performance of -4.53%. Its 52-week range is between 60.83 and 87.84, which gives CNC stock a 52-week price range ratio of 30.17%

Centene Corporation currently has a PE ratio of 22.90, a price-to-book (PB) ratio of 1.76, a price-to-sale (PS) ratio of 0.40, a price to cashflow ratio of 5.40, a PEG ratio of 2.04, a ROA of 2.74%, a ROC of 5.24% and a ROE of 8.43%. The company’s profit margin is 1.30%, its EBITDA margin is 3.40%, and its revenue ttm is $108.99 Billion , which makes it $192.47 revenue per share.

Of the last four earnings reports from Centene Corporation, there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $1.47 for the next earnings report. Centene Corporation’s next earnings report date is 24th Oct 2023.

The consensus rating of Wall Street analysts for Centene Corporation is Moderate Buy (2.06), with a target price of $100, which is +44.97% compared to the current price. The earnings rating for Centene Corporation stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Centene Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Centene Corporation has a Neutral technical analysis rating based on Technical Indicators (ADX : 7.29, ATR14 : 1.50, CCI20 : 16.10, Chaikin Money Flow : 0.06, MACD : 1.02, Money Flow Index : 42.12, ROC : 0.63, RSI : 53.41, STOCH (14,3) : 27.59, STOCH RSI : 0.00, UO : 48.56, Williams %R : -72.41), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Centene Corporation in the last 12-months were: Andrew Lynn Asher (Buy at a value of $489 156), Asher Andrew (Buy at a value of $489 156), James E. Murray (Buy at a value of $494 775), London Sarah (Buy at a value of $1 878 000), Robinson Lori (Sold 1 400 shares of value $93 226 ), Sarah M. London (Buy at a value of $1 878 000), Theodore R. Samuels (Buy at a value of $503 160)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
8 (47.06 %)
8 (50.00 %)
8 (50.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
1 (6.25 %)
Hold
9 (52.94 %)
7 (43.75 %)
6 (37.50 %)
Moderate Sell
0 (0.00 %)
1 (6.25 %)
1 (6.25 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.06
Moderate Buy
2.06
Moderate Buy
1.97

Centene Corporation

Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. After acquiring WellCare in early 2020, Centene now serves 21 million medical members, mostly in Medicaid (14 million), Medicare Advantage (1 million total), the individual exchanges (2 million), and other plans (4 million), including Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.

CEO: Michael F. Neidorff

Telephone: +1 314 725-4477

Address: 7700 Forsyth Boulevard, St. Louis 63105, MO, US

Number of employees: 71 300

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

57%43%

Bearish Bullish

57%43%

 

TipRanks News for CNC

Thu, 07 Sep 2023 13:55 GMT Early notable gainers among liquid option names on September 7th

- TipRanks. All rights reserved.

Wed, 30 Aug 2023 13:40 GMT Unusually active option classes on open August 30th

- TipRanks. All rights reserved.

Wed, 02 Aug 2023 06:55 GMT Centene (CNC) Gets a Hold from Mizuho Securities

- TipRanks. All rights reserved.

Mon, 31 Jul 2023 05:15 GMT Centene (CNC) Gets a Hold from Goldman Sachs

- TipRanks. All rights reserved.

Mon, 31 Jul 2023 01:15 GMT Centene (CNC) Receives a Buy from Barclays

- TipRanks. All rights reserved.

Wed, 12 Jul 2023 08:30 GMT Analysts Have Conflicting Sentiments on These Healthcare Companies: Centene (CNC) and Standard BioTools (LAB)

- TipRanks. All rights reserved.

News

Stocktwits